DNA

Helmsley Grant to UFDI to Study Immune Repertoire in T1D

University of Florida and Kings College London have secured a $3.7 million grant funded by Adaptive Biotechnologies and the Leona M. and Harry B. Helmsley Charitable Trust to profile T […]

TIGIT

Join Our Mission

The Brusko Lab is currently recruiting a Postdoc to work on our NIH R01 “The CD226 and TIGIT Costimulatory Axis in Type 1 Diabetes.”

TrialNet

ATG Preserves β-Cell Function in Clinical Trial

The 1-year C-peptide was significantly higher (β-cell preservation) in subjects treated with ATG versus placebo (P = 0.0003) but not in those treated with ATG/GCSF versus placebo (P = 0.031).

Figure 2

What’s your GRS?

The Brusko Lab and collaborators are trying to better understand how genes influence T1D risk

Our Research Focus

Our laboratory aims to harness the power of naturally occurring regulatory T cells to correct unwanted immune responses that deliver a cure for type 1 diabetes.

Peeps

Our Staff

From undergraduate students to post-doctoral fellows – every set of hands is important.

Prev Next

Contact Us

I am among those who think that science has great beauty. A scientist in his laboratory is not only a technician: he is also a child placed before natural phenomena which impress him like a fairy tale.

-Marie Curie